By Leroy Leo and Aditya Samal (Reuters) – Johnson & Johnson will look for opportunities to merge with or acquire…
Seattle public schools blame tech giants for social media harm in lawsuit
(Reuters) -Seattle’s public school district filed a lawsuit against Big Tech claiming that the companies were responsible for a worsening…
Teva says opioids settlement to move forward in U.S
(Reuters) -Israeli drugmaker Teva Pharmaceutical Industries Ltd said there was sufficient participation from U.S. states and local authorities to move…
Novavax’s longtime CEO Stanley Erck to retire
(Reuters) – Novavax Inc said on Monday its longtime chief executive officer, Stanley Erck, would retire and be succeeded by…
Qiagen acquires DNA-biometrics firm Verogen in $150 million deal
(Reuters) – Life sciences firm Qiagen said on Monday it has acquired DNA-biometrics firm Verogen in a $150-million cash deal,…
Private equity acquires a taste for drug development
By David Carnevali (Reuters) – Private equity firms that deemed drug development too risky for their liking in the past…
French drug company Servier launches Mediator appeal
PARIS (Reuters) – French drugmaker Servier on Monday launched its appeal against manslaughter and deception convictions handed down by a…
Eisai, Biogen’s Alzheimer’s drug price should not dent demand – analysts
(Reuters) – The $26,500-per-year price tag for Eisai Co Ltd and Biogen Inc’s newly approved Alzheimer’s disease drug is slightly…
AstraZeneca boosts heart, kidney business with $1.8 billion CinCor deal
By Natalie Grover (Reuters) -AstraZeneca said on Monday it had struck a deal to buy U.S.-based drug developer CinCor Pharma…
Moderna generates $18.4 billion in COVID vaccine sales in 2022
(Reuters) – Moderna Inc said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022. (Reporting by…